| Title: |
The Role of the Gut Microbiota in Sanfilippo Syndrome's Physiopathology: An Approach in Two Affected Siblings. |
| Authors: |
Barbero-Herranz, Raquel1 (AUTHOR) rql1898@gmail.com, Garriga-García, María2 (AUTHOR) maria.garriga@salud.madrid.org, Moreno-Blanco, Ana1,3 (AUTHOR) anamorenoblanco1993@gmail.com, Palacios, Esther1 (AUTHOR) esthepalgo@gmail.com, Ruiz-Sala, Pedro4,5 (AUTHOR) pedro.ruiz@inv.uam.es, Vicente-Santamaría, Saioa2 (AUTHOR) saioa.vicente@salud.madrid.org, Stanescu, Sinziana6 (AUTHOR) sinziana.stanescu@salud.madrid.org, Belanger-Quintana, Amaya6 (AUTHOR) amaya.belanguer@salud.madrid.org, Pintos-Morell, Guillem7 (AUTHOR) guillempintos@gmail.com, Arconada, Beatriz8 (AUTHOR) b.arconada@enfermedades-raras.org, del Campo, Rosa1,3,9 (AUTHOR) rosacampo@yahoo.com, Avendaño-Ortiz, José1,3 (AUTHOR) rosacampo@yahoo.com |
| Source: |
International Journal of Molecular Sciences. Aug2024, Vol. 25 Issue 16, p8856. 15p. |
| Subject Terms: |
*SANFILIPPO syndrome, *GUT microbiome, *HEPARAN sulfate, *CONGENITAL disorders, *QUALITY of life, *BACTEROIDES fragilis |
| Abstract: |
Sanfilippo syndrome, or mucopolysaccharidosis type III (MPS III), is a rare lysosomal disease caused by congenital enzymatic deficiencies in heparan sulfate (HS) degradation, leading to organ dysfunction. The most severe hallmark of MPS III comprises neurological alterations, although gastrointestinal symptoms (GISs) have also been shown to be relevant in many patients. Here, we explored the contribution of the gut microbiota to MPS III GISs. We analyzed the composition and functionality of the gut microbiota in two MPS III siblings with the same mutation (c.544C > T, c.1080delC, in the SGSH gene) and the same diet, but with differences in their GISs, including recurrent diarrhea in one of them. Using 16S sequencing, we observed that the MPS III patients exhibited decreased alpha diversity and a lower abundance of Lachnospiraceae and Bifidobacteriaceae accompanied by a higher abundance of the Ruminococcaceae and Rikenellaceae families than the healthy control subjects. Comparing siblings, we found an increased abundance of Bacteroidaceae and a lower abundance of Ruminococcaceae and Akkermansiaceae in the GIS-free patient. This patient also had a higher relative abundance of Sus genes (SusA, SusB, SusE, and SusG) involved in glycosaminoglycan metabolism. We found higher HS levels in the stool of the two MPS III patients than in healthy volunteers, particularly in the patient with GISs. Functionally, whole fecal metabolites from the patient with GISs induced oxidative stress in vitro in healthy monocytes. Finally, the Bacteroides thetaiotaomicron strain isolated from MPS III stool samples exhibited HS degradation ability. Overall, our results reveal different microbiota compositions and functionalities in MPS III siblings, who exhibited differential gastrointestinal symptomatology. Our study may serve as a gateway to explore the impact of the gut microbiota and its potential to enhance the quality of life in Sanfilippo syndrome patients. [ABSTRACT FROM AUTHOR] |
|
Copyright of International Journal of Molecular Sciences is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
|
Full text is not displayed to guests. |
Login for full access.
|
